Grants

RepRegen has received the following grants:

TSB1 – Technology Strategy Board (2008-2012) development of a ceramic-polymer plug for treating osteochondral defects of the knee and to assess performance with and without autologous / allogeneic progenitor chondrogenic and osteogenic cells.

TSB2 - Technology Strategy Board (2009-2010) feasibility scale-up study to develop a porous strontium bioactive glass synthetic bone graft (StronBone-P).

TSB3 - Technology Strategy Board (2009-2010) feasibility scale-up study to develop a porous hybrid nanocomposite (silicate-biopolymer) with load sharing / bearing characteristics for tissue regeneration.

TSB4 - Technology Strategy Board (2010-2011) continuation project of TSB2 to commercialise a porous strontium bioactive glass synthetic bone graft (StronBone-P) and gather further comparative performance data on CE Marked StronBone.

TSB5 - Technology Strategy Board (2010-2011) project to develop an injectable strontium bioactive glass-polymer bone substitute which sets in situ.